Punjab Alkalies & Chemicals Limited

   
 
PUNJAB ALKALIES & CHEMICALS LIMITED
           
Unaudited Financial Results (Provisional)  for the Quarter  Ended 31st December, 2005
 
            (Rs. in Lakhs)
Sr. Particulars Quarter Quarter Nine Months Nine Months Previous  Accounting
No.   Ended Ended Ended Ended Year Ended 
    31.12.2005 31.12.2004 31.12.2005 31.12.2004 31.3.2005
    (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited)
1 Sales (incl.Excise Duty) 5250.76 5971.12 18514.70 14974.36 20713.42
  Excise Duty 755.14 869.02 2690.76 2138.81 2952.11
  Net Sales 4495.62 5102.10 15823.94 12835.55 17761.31
2 Other Income 94.37 19.61 229.55 81.38 232.59
3 Total Expenditure          
  a) (Increase)/Decrease in stock in trade 8.33 (56.35) (69.62) (47.01) 15.43
  b) Consumption of raw materials, power & fuel etc. 3299.45 2778.88 10187.45 8226.16 10917.74
  c) Purchase of trading items 50.78 - 50.78 - -
  d) Staff Cost 420.23 334.03 1047.75 846.70 1257.17
  e) Other Expenditure 297.56 230.78 1108.68 721.22 1122.08
4 Gross Profit before interest & depreciation 513.64 1834.37 3728.45 3169.86 4681.48
5 Interest 346.38 347.26 1021.65 1013.45 1376.63
6 Profit before depreciation 167.26 1487.11 2706.80 2156.41 3304.85
7 Depreciation etc. 333.36 323.59 1012.14 947.11 1283.66
8 Net Profit/(Loss) before taxation (166.10) 1163.52 1694.66 1209.30 2021.19
9 a) Provision for Taxation - MAT - - 139.64 - -
  b) Fringe Benefit Tax 5.86 - 12.05 - -
10 Net Profit/(Loss) after taxation (171.96) 1163.52 1542.97 1209.30 2021.19
11 Paid up equity capital (Face Value Rs.10/-) 2049.92 2046.72 2049.92 2046.72 2046.72
12 Reserves excluding revaluation reserves - - - - 3624.16
13 Earnings/(Loss) per Share (Rs.) (Not Annualised)          
  a) Basic (0.84) 5.68 7.54 5.91 9.87
  b) Diluted (0.84) 2.77 2.80 2.88 4.09
14 Aggregate of Non-promoter Shareholding:          
  a) Number of Shares 11445550 11445550 11445550 11445550 11445550
  b) Percentage of Shareholding 55.74% 55.74% 55.74% 55.74% 55.74%
 
 

Notes:

1. The Company   has accounted for interest as per the   Revised   Restructuring   Package   approved   by  the Corporate Debt  Restructuring  (CDR)  Empowered  Group  at  the  maximum  interest  rate  of  10.5% p.a.   in  case  of all lenders except  ICICI  Bank  Limited,  Bank  of Punjab Limited and Punjab & Sind Bank  where the interest has been accounted for @  6% p.a., 5.26% p.a. and 9% p.a., respectively.

2. The Company has revalued its Fixed Assets (other than the 100 TPD Membrane Cell Plant Power Line) as on 31st March,  2004 on the basis of existing use value by an  independent  professional  valuer.   The  revaluation  of   assets  has  been  approved by the Board of Directors in its meeting held on 27th October, 2005. Accordingly, a sum of Rs.6243.16 lakhs being the surplus of  the value of assets over the written down value, has been credited to the Revaluation Reserve. The Depreciation  for  the  quarter  ended 31st December, 2005 charged to  Profit  &  Loss  Account  does  not  include  the depreciation arising on revaluation of Fixed Assets for the period 1st April, 2004 to 31st December, 2005.

3. The  Company operates  in a single  business  segment  viz., Chemicals. Hence segment reporting  under AS - 17 is not applicable.

4. The  Company has not recognised  the  Deferred Tax Assets in respect of the losses under AS-22  in  view of the carried  forward losses.

5. The Company did not have any investor complaint / query pending  at  the beginning of the quarter ended 31st December, 2005.   The    Company    received 14  investor   complaints/queries  during   the  said quarter, which  were disposed  off. There were no investor complaints/queries pending at the end of the said quarter.

6. The above results were taken on record by the Board in its meeting held on 25th January, 2006.

                                                                                                             

Return to Home Page

ABOUT US | HUMAN RESOURCES | QUALITY POLICY | ENVIRONMENT POLICY | PRODUCTS | CAREERS | CORPORATE PERFORMANCE

The Chemistry of Excellence